NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer
NCT02425072
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
slow accrual
Conditions
Small Cell Lung Cancer
Brain Metastasis
Interventions
DEVICE:
NovoTTF-100A plus chemotherapy
Sponsor
John Villano